Company · CIK 0001611747 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Scinai Immunotherapeutics Ltd. · SCNI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 AForm 4 → | Jun 18, 2:51 pm EDT | Mark GermainDirector | 120,000,000 | — | — | 120,000,000 | — | |
| Jun 16, 2026 AForm 4 → | Jun 18, 2:48 pm EDT | Amir ReichmanChief Executive Officer, Director | 400,000,000 | — | — | 711,637,600 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.